FDA Issues Alert on Recalled Irbesartan Due to Contamination

Testing confirmed the presence of the impurity NDEA in recalled lots of irbesartan from SciGen Pharmaceuticals and in the active substance supplied to the US market by Aurobindo Pharma.
News Alerts